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Abstract
Aims and objectives: In this present study we have evaluated the feasibility of sub-classification of non-Hodgkin's
lymphoma (NHL) cases according to World Health Organization's (WHO) classification on fine needle aspiration
cytology (FNAC) material along with flow cytometric immunotyping (FCI) as an adjunct.
Materials and methods: In this five years study, only cases suggested or confirmed as NHL by FNAC were selected
and FCI was performed with a complete panel of antibodies (CD3, CD2, CD 4, CD5, CD8, CD7, CD10, CD19, CD20,
CD23, CD45, κ and λ) by dual color flow cytometry. Both cytologic findings and FCI data were interpreted together to
diagnose and sub-classify NHL according to WHO classification. Wherever possible the diagnoses were compared with
cytology.
Results: There were total 48 cases included in this study. The cases were classified on FNAC as predominant small cells
(12), mixed small and large cells (5) and large cells (26). In five cases a suggestion of NHL was offered on FNAC material
and these cases were labeled as NHL not otherwise specified (NHL-NOS). Flow cytometry could be performed in 45
cases (93.8%) and in rest of the three cases the material was inadequate because of scanty blood mixed aspirate. Light
chain restriction was demonstrated in 30 cases out of 40 cases of B-NHL (75%). There were 15 cases each of κ and λ
light chain restriction in these 30 cases. With the help of combined FCI and FNAC, it was possible to sub-classify 38 cases
of NHL (79%) according to WHO classification. Combined FNAC and FCI data helped to diagnose 9 cases of small
lymphocytic lymphoma (SLL), 2 cases of mantle cell lymphoma (MCL), 4 cases of follicular lymphoma (FL), 17 cases of
diffuse large B lymphoma (DLBL) and 6 cases of lymphoblastic lymphoma. Histopathology diagnosis was available in 31
cases of NHL out of which there were 14 recurrent and 17 cases of primary NHL. Out of 15 DLBL cases diagnosed on
FCI and FNAC, histology confirmed 14 cases and one of these cases was diagnosed as Burkitt's lymphoma on histology.
Cases of FL (4), SLL (3) and MCL (2) were well correlated with histopathology. Out of the five cases suggestive of NHL
on cytology, histopathology was available in four cases. Histology diagnosis was given as DLBL (1), SLL (1), anaplastic large
cell lymphoma (1) and FL transformed into large cell NHL (1). Considering histopathology as gold standard, diagnostic
specificity of combined FNAC and FCI was 100% (31/31) and sensitivity in sub-classification was 83.8% (26/31).
Conclusion:  FNAC combined with FCI may be helpful in accurately sub-classifying NHL according to WHO
classification. Many of the subtypes of NHL such as FL and MCL which were previously recognized as a pure morphologic
entity can be diagnosed by combined use of FNAC and FCI. Other ancillary investigations such as chromosomal changes,
cell proliferation markers etc. may be helpful in this aspect.
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Background
Fine needle aspiration cytology (FNAC) is a very helpful
technique in diagnosis of benign and malignant lesions of
lymph node [1-4]. Many authors also claim that FNAC
can accurately diagnose Hodgkin's and non-Hodgkin's
lymphoma (NHL)[5,6]. However there is a wide variation
of diagnostic sensitivity and specificity of FNAC in non-
Hodgkin's lymphoma [5-8]. The role of cytology in pri-
mary diagnosis and sub-classification of non-Hodgkin's
lymphoma is controversial [9-12]. After the introduction
of REAL/WHO classification, there is much difference in
the cytologist's approach of lymphoma diagnosis and
classification. WHO and REAL classification emphasized
immense importance on the cytomorphology and immu-
nophenotype of lymphoma for accurate sub classification
[13,14]. In this present study we have analyzed the role of
flow cytometric immunotyping as an adjunct to FNAC for
diagnosis and sub-classification of NHL according to
WHO classification.
Materials and methods
This study is of five years duration from the year 2000 Jan-
uary to 2004 December. Only cases suggested or con-
firmed as NHL by FNAC were selected. FNAC smears were
prepared for May Grunwald Giemsa (MGG) and Haema-
toxyline and Eosin stain in each case. The May Grunwald
Giemsa smears were studied immediately. A second pass
of the needle was done and material was collected in cit-
rate buffer for flow cytometric immunophenotyping
(FCI). The specimen was immediately processed and a
complete panel of antibodies was used for immunophe-
notyping. Both cytologic findings and FCI data were inter-
preted together to diagnose and sub-classify NHL
according to WHO classification as far as possible. Wher-
ever possible the final histological diagnosis was corre-
lated with FNAC and FCI diagnosis.
Specimen preparation
FNAC material was collected in citrate buffer solution and
immediately transferred to flow cytometry laboratory. The
sample was washed in phosphate buffer solution three
times for 5 minutes at 2000 revolutions per minute. The
supernatant fluid was discarded and the deposits of cells
were studied for cell viability and count. After that, the
suspension was divided into multiple tubes depending on
the adequacy of the cell. Samples were then incubated for
15 minutes in dark with 5 μl of antibody solution tagged
with Fluorescein isothyocyanate (FITC) or Phycoerythrin
(PE). The following antibodies were used: CD3, CD2, CD
4, CD5, CD8, CD7, CD10, CD19, CD20, CD23, CD45, κ
and λ. (Becton Dicikinson, San Jose, CA, USA). After incu-
bation, red blood cells were lysed by a lysing solution
(Becton Dicikinson, USA, Catalogue no 349202) for 15
minutes and then washed by a cell wash solution (Becton
Dicikinson, USA, Catalogue no 349524). After centrifug-
ing, the supernatant solution was discarded and 500 μl
cell fixative was added (Becton Dicikinson, Catalogue no
340181). Flow cytometry analysis was then performed in
Becton Dicikinson flow cytometer (San Jose, CA, USA) by
dual-color analysis technique. Gating was done using for-
ward and side scatter and also by the help of Cell Quest
software (San Jose, CA, USA). We analyzed a minimum
number of 10,000 events for each cell marker.
Results
There were total 48 cases included in this study and in all
these cases FNAC confirmed or suggested the diagnosis of
NHL. Age of the patients ranged from 6 year to 78 years.
There were 34 male and 14 female patients. Twenty-nine
cases were first time investigated in our FNAC clinic for
primary diagnosis and 19 cases were recurrent NHL. In 36
cases, the masses were palpable and FNAC was done with-
out any radiological guidance (table 1). In 12 cases masses
were non-palpable and FNAC was done with the help of
Ultrasonographic guidance. FNAC yielded adequate
material in all these deep-seated cases. The cases were clas-
sified on FNAC as predominant small cells (12), mixed
small and large cells (5) and large cells (26) [table 2]. In
five cases a suggestion of NHL was offered on FNAC mate-
rial and these cases were labeled as NHL not otherwise
specified (NHL-NOS). Flow cytometry could be per-
formed in 45 cases (93.8%) and in rest of the three cases
the material was inadequate because of scanty blood
mixed aspirate. There were total 40 cases of B-NHL. These
cases showed predominant CD19 and CD20 positive cell
population. Light chain restriction (figure 1) could be
demonstrated in 30 out of 40 cases of B-NHL (75%).
There were 15 each cases of κ and λ light chain restriction.
In 10 cases there was no demonstrable light chain restric-
tion on FCI. However cytology smears and predominant
population of CD19 cells indicated a NHL of B cell origin.
The diagnostic distribution of cases on the basis of FCI is
highlighted in table 2. With the help of combined FCI and
Table 1: Anatomic distribution of aspirated lesions
Sites Number of patients
Palpable
Cervical lymph node 19
Inguinal lymph node 3
Axillary lymph node 8
Submandibular lymph node 3
Supraclavicular lymph node 2
Skin 1
Ultra Sonogram guided
Abdominal lymph node 6
Bowel wall 2
Mediastinum 3
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FNAC, it was possible to sub-classify 38 cases of NHL
(79%) according to WHO classification (table 3). Out of
the 12 cases of small cell NHL, with the help of FCI we
were able to diagnose a total of 8 cases of small lym-
phocytic lymphoma (SLL), 2 cases of mantle cell lym-
phoma (MCL) and one case of follicular lymphoma (FL).
Due to inadequate material, no opinion was possible on
FCI in one case of NHL. The SLL cases showed CD 19 and
CD 20 positive cell population along with expression of
CD5 and CD23 (figure 2, 3). Individual cells show round
to oval small nuclei and clumped chromatin with no
nucleoli (figure 4). In contrast, MCL lymphoma showed
CD 19 and CD 20 positive cell population along with
CD5 positive and CD23 negative marker. However on
FNAC smears it was impossible to distinguish SLL and
MCL by cytology alone.
There were 5 cases of mixed small and large cell NHL, and
out of which three cases were diagnosed as follicular lym-
phoma (FL) and two cases remained unclassified even
after FCI as these cases did not show CD 10 positivity on
FCI. The cases of FL showed CD10 positive cell popula-
tion along with CD19 and CD20 positivity. Cytology
smears showed mixed population of small and large
round cells with scanty cytoplasm. Individual cells had
round nuclei, fine chromatin and inconspicuous nucleoli
(figure 5).
Out of 26 cases of large cell NHL, there were 16 cases of
diffuse large B lymphoma (DLBL), 6 cases of lymphoblas-
tic lymphoma and three cases remained unclassified. No
opinion could be given on FCI in one case. DLBL cases
showed B cell markers positivity (CD 19 and CD 20 posi-
tive cell population). Cytology smears of these cases
Table 3: Combined Cytology and flow cytometry diagnosis









No opinion on FCI, but diagnosed as NHL on FNAC 3
DLBL = Diffuse large B lymphoma, SLL = Small lymphocytic 
lymphoma, FL = Follicular lymphoma, MCL = Mantle cell lymphoma, 
FNAC = Fine needle aspiration cytology, NHL = Non Hodgkin's 
lymphoma, FCI = Flow immunophenotyping
Table 2: Cytology and flow cytometry, diagnosis
FNAC FCI
DLBL FL SLL MCL T-lymphoblastic NHL B-lymphoblastic NHL NHL-unclassified No opinion
Small cell 12 1 8 2 1
Mixed cell 5 3 2
Large cell 26 16 5 1 3 1
Suggestive of NHL 5 1 1 2 1
DLBL = Diffuse large B lymphoma, SLL = Small lymphocytic lymphoma, FL = Follicular lymphoma, MCL = Mantle cell lymphoma, FNAC = Fine 
needle aspiraition cytology, NHL = Non Hodgkin's lymphoma, FCI = Flow immunophenotyping
kappa light chain restriction in a case of B-non Hodgkin's lym- phoma Figure 1
kappa light chain restriction in a case of B-non Hodgkin's lym-
phoma.CytoJournal 2006, 3:24 http://www.cytojournal.com/content/3/1/24
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showed monomorphic population of large cells with fine
nuclear chromatin and occasional prominent nucleoli
(figure 6). There were six cases of lymphoblastc lym-
phoma on cytology smears and FCI showed B cell marker
positivity in one cases and T cell marker positivity in five
cases. The cytology smears of these cases showed dissoci-
ated large cells with reticular chromatin and inconspicu-
ous nucleoli (figure 7).
Cytology smear of a case of follicular lymphoma showing  mixed small and large cells Figure 5
Cytology smear of a case of follicular lymphoma showing 
mixed small and large cells. (Haematoxylene and Eosin stain).
CD23 and CD19 positivity in that same case of small lym- phocytic lymphoma Figure 3
CD23 and CD19 positivity in that same case of small lym-
phocytic lymphoma.
CD5 and CD20 positivity in a case of small lymphocytic lym- phoma Figure 2
CD5 and CD20 positivity in a case of small lymphocytic lym-
phoma.
Cytology smear of small Lymphocytic lymphoma showed  small cells with clumped chromatin Figure 4
Cytology smear of small Lymphocytic lymphoma showed 
small cells with clumped chromatin. (Haematoxylene and 
Eosin stain).CytoJournal 2006, 3:24 http://www.cytojournal.com/content/3/1/24
Page 5 of 8
(page number not for citation purposes)
Five cases were diagnosed as suggestive of NHL. With the
help of FCI, Sub classification was possible only in two
cases (one each case of DLBL and SLL). In two other cases,
FCI just confirmed the presence of lymphomas. One of
these two cases was finally diagnosed as FL transformed
into blastic phase on histopathology. The other case was
labeled as lymphoma (not otherwise specified). This case
showed predominant CD 19 and CD 20 positivity (80
and 82%) and κ chain expression only. No other marker
was positive to help in subclassification of this lym-
phoma. Histopathology of this case was also not availa-
ble. In the fifth case, FCI was inadequate for any opinion
and this case was finally diagnosed on histopathology as
anaplastic large cell lymphomas. Cytology smear of this
case showed dissociated large atypical cells with mild to
moderate nuclear pleomorphism having prominent
nucleoli (figure 8).
Histopathology diagnosis was available in 31 cases of
NHL and out of which there were 14 recurrent and 17 pri-
mary NHL. Table 4 shows the correlation between com-
bined FNAC and FCI diagnosis versus histology diagnosis.
Out of 15 DLBL cases on FCI and FNAC, histology con-
firmed 14 cases. One case was diagnosed as Burkitt's lym-
phoma. Cases of FL (4), SLL (3) and MCL (2) were well
correlated with histopathology. Out of the five cases of
suggestive of NHL on cytology, histopathology was avail-
able in four cases. Histopathology of these cases showed
DLBL (1) and SLL (1), anaplastic large cell lymphoma (1)
and FL transformed into large cell NHL (1). Diagnostic
specificity of combined FNAC and FCI was 100% (31/31)
and sensitivity in sub-classification was 83.8% (26/31) in
accordance with histopathology.
Discussion
FNAC has been widely used for the rapid diagnosis of
metastatic malignancies, infectious diseases and reactive
lymphoid hyperplasias [1-4]. However there is a wide
divergence of opinions regarding the role of FNAC on pri-
mary diagnosis and sub-classification of NHL on FNAC
smears [9-12]. This difficulty is particularly problematic
when a less than pure monomorphic lymphocyte popula-
Cytology smear of a case of anaplastic large cell lymphoma  showing dissociated cells with moderately pleomorphic large  nuclei Figure 8
Cytology smear of a case of anaplastic large cell lymphoma 
showing dissociated cells with moderately pleomorphic large 
nuclei. (Haematoxylene and Eosin stain).
Aspiration cytology smear of a diffuse large B cell lymphoma  showing large lymphoid cells with fine chromatin and occa- sional prominent nucleoli Figure 6
Aspiration cytology smear of a diffuse large B cell lymphoma 
showing large lymphoid cells with fine chromatin and occa-
sional prominent nucleoli. (May Grunwald Giemsa stain).
Aspiration cytology smear of a case of lymphoblastic lym- phoma showing large cell with reticular chromatin and incon- spicuous nucleoli Figure 7
Aspiration cytology smear of a case of lymphoblastic lym-
phoma showing large cell with reticular chromatin and incon-
spicuous nucleoli. (May Grunwald Giemsa stain).CytoJournal 2006, 3:24 http://www.cytojournal.com/content/3/1/24
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tion exists in the smears. A major disadvantage inherent in
the FNAC smear is the inability to identify a follicular
growth pattern [15], which is a major prognostic factor.
After the introduction of REAL and WHO classification,
the major emphasis has been given on cell morphology
and immunopheotype rather than the growth pattern
[13,14]. In the present paper, we attempted to apply the
combined approach of FNAC and FCI to implement
WHO classification on FNAC. FCI showed light chain
restriction in 75% (30/40) cases of B-NHL. In rest of the
ten cases, there were predominant CD19 and CD20 posi-
tive cell populations (>80%). Considering the cytomor-
phology and predominant CD 19 and CD20 expression,
we considered these cases as B-NHL. The lack of expres-
sion of surface immunoglobulin light chains in B-NHL is
an unusual phenomenon. However, it has been also
noted by other authors [16,17]. Zardawi et al [17]
encountered seven cases of B-NHL, which did not show
any light chain restriction on FCI. Similarly Zeepa et al
[16] noted 12 cases of B-NHL with no demonstrable light
chain restriction. In fact, it has been suggested by them
that CD20 positivity in excess of 85% is diagnostic of NHL
in a cytological suspicious case of lymphoma [16].
In addition to providing clear, quantitative evidence of
monclonality, FCI was helpful in subclassification of NHL
in 79% (38/48) cases. It was particularly helpful in sub-
classification of low grade B-NHL. The FNAC of small
lymphocytic lymphomas, mantle cell lymphomas and
low grade follicular lymphomas are difficult to differenti-
ate by cytomorphology alone. Combining CD 19 with
other antibodies such as CD 5, CD10, CD 23 and FMC 7
are usually helpful to distinguish these lesions. In the
present study, all the SLL cases, expressed both CD5 and
CD 23 antigen. SLL cases usually show absence of expres-
sion of CD 10 and FMC 7. Typically they show a low pro-
liferative index. In MCL, we noted only CD5 positive and
CD23 negative population of cells. We did not have FMC
7 antibody in our laboratory for additional confirmation
in MCL cases. MCL is associated with characteristic
cytogenesis abnormality of t(11:14). This anomaly causes
overexpression of BCL1 gene, which encodes cycin D1. So
MCL are positive for cyclin D1 in addition to CD 5 posi-
tivity. This is an additional characteristic feature of MCL
[18]. CD 10 expression along with other B cell markers
(such as CD19/CD 20), was useful in diagnosis of FL.
These cases were negative for CD5. However in two cases
CD10 positivity was not demonstrated and a confident
diagnosis of FL was not possible. The FL is associated with
the charateristics t(14:18)(q32;21) translocation. This can
be demonstrated on cytology smears with the help of flu-
orescent in situ hybridisation (FISH) [19]. This reciprocal
translocation may lead to oberexpression of BCL2 protein
[20]. Demonstration of BCL2 protein overexpression may
be helpful in histology sections where architecture is pre-
served.
FCI alone was not very helpful in distinguishing DLBL,
lymphoblastic lymphoma and Burkitt's lymphoma, and
in those cases cytomorphology on the FNAC smears was
important. Lymphoblastic lymphomas are positive for
early markers such as TdT and CD34. B cells may also
express pan B-cell makers such as CD20 and lack surface
and sometimes cytoplasmic immunoglobulin. We did not
have adequate standardization of TdT and so we relied on
cytomrphology to diagnose lymphoblastic lymphomas.
The T-lymphoblastic lymphomas showed variable posi-
tivity of CD3, CD2 and CD10 markers. Wheras B-lym-
phoblastic lymphomas showed varaiable expression of
CD19, CD20 and CD10. Careful history and peripheral
blood picture should always take into consideration as
Acute myeloid leukaemia (AML-M0) may simulate simi-
lar picture. The Burkitt's lymphomas have characteristic
cytomorphology. FNAC smears show dissociated cells
with deep blue vacuolated cytoplasm, having round regu-
lar nuclei with prominent nucleoli and abundant tingible
body macrophages in the background. High cell prolifer-
ation markers (Ki 67 index more than 99%) and t
(8;14)(q24;q32) translocation are the characteristic fea-
tures of Burkitt's lymphomas [13]. The Burkitt lympho-
Table 4: Combined FNAC and FCI versus available histopathology diagnosis
Combined FNAC and FCI diagnosis Histology diagnosis
DLBL FL SLL MCL Lymphob lastic Other





Suggestive of NHL (4) 1 1 1 ALCL
1 FL to large B-NHL
DLBL = Diffuse large B lymphoma, SLL = Small lymphocytic lymphoma, FL = Follicular lymphoma, MCL = Mantle cell lymphoma, ALCL = Anaplastic 
large cell lymphoma, FNAC = Fine needle aspiration cytology, NHL = Non Hodgkin's lymphoma, FCI = Flow immunophenotypingCytoJournal 2006, 3:24 http://www.cytojournal.com/content/3/1/24
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mas always express pan – B cell markers and are positive
for CD 1O and lack expression of early markers such as
CD 34 and TdT.
In this study we applied FCI to diagnose and subclassify
NHL on FNAC smears according to WHO classification.
There are a few available studies in this aspect [16,21-23].
Zeppa P et al [16] in a similar study, were able to subclas-
sify 70 cases of NHL among the 115 cases of NHL with
small and medium sized cells. Expression and coexpres-
sion of different CD markers were helpful in their study
for subtyping NHL. In a similar study, Siebert JD et al [21]
were able to subtype 29/38 (76.3%) NHL with the help of
FCI. They also highlighted that adjunctive FCI and FNAC
is potentially practicable in a community hospital and can
help direct lymphoma therapy. Mourad et al[22] also
were able to subclassify large number of cases according to
WHO subclassification with the help of FCI. Mayall et al
[23] in a recent paper showed that FNAC along with FCI
were very helpful to diagnose and subclassify B cell NHL.
But FCI had litlle use for T cell NHL in their study. Our
study was also comparable with the above mentioned
studies as we were also able to subclassify 83% of histopa-
thology proven cases. We also were able to subclassify the
large number of small cell B-NHL. It was not very inform-
ative in large cell type of B-NHL. In these cases cytomor-
phologic feature are helpful in subclassification of NHL.
FCI is also likely to miss difficult cases such as ALCL. Mon-
oclonality was difficult to prove in T-NHL on FCI, how-
ever aberrant expression of T cell markers and
predominant expression of CD4 or CD8 indicated T cell
NHL.
Other ancillary techniques such as cell proliferation mark-
ers, molecular markers etc. may be helpful in identifying
certain type of NHL [18,24]. FCI of marzinal zone lym-
phoma is not characteristic and demonstration of t(11:
18) (q21:21) may be required [25]. Similarly transloca-
tion of t(8: 14) is characteristics of Burkitt's lymphoma
and it involves c-myc oncogene expression [26]. Anaplas-
tic large cell lymphoma has specific t(2:5) translocation
and ALK 1 positivity may be a helpful marker in this vari-
ety of NHL [27].
FCI is a rapid technique and it helped us to objectively
asses the monoclonality of the cell population. With the
help of FCI, we quantiatatively estimated the cell popula-
tion expressing particular CD markers and this was very
helpful for subclassification of NHL according to WHO
classificartion. In most of our cases adequate number of
cells were present in FNAC material. The demonstration
of expression of large number of CD markers in the lym-
phoid cell population was possible with the help of FCI.
There is one advantage of FCI over routine immunocyto-
chemistry. With the help of FCI, it is possible to see the co-
expression of different CD markers in a single cell. This is
particularly helpful in distinguishing SLL and MCL.
In brief, FNAC combined with FCI may be helpful in accu-
rately subclassifying NHL according to WHO classifica-
tion. Many of the subtypes of NHL such as FL and MCL
which were previously recognized as a pure morphologic
entity can be diagnosed by combined use of FNAC and
FCI. Other ancillary investigations such as chromosomal
changes, cell proliferation markers etc. may be helpful in
this aspect [18]. In future FNAC supported by FCI and
other ancillary investigations may replace excision tissue
biopsy for histopathology particularly in recurrent cases
of NHL.
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